JAC Advance Access originally published online on September 13, 2005
Journal of Antimicrobial Chemotherapy 2005 56(5):965-967; doi:10.1093/jac/dki334
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients
1 Department of Microbiology and Institute of Biomedical Science, Hanyang University College of Medicine, Seoul, 2 Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea
Received 9 July 2005; returned 7 August 2005; revised 22 August 2005; accepted 22 August 2005
* Correspondence address. Department of Microbiology, Hanyang University College of Medicine, 17 Haengdang-dong, Sungdong-gu, Seoul 133–791, Korea. Tel: +82-2-2220-0645; Fax: +82-2-2282-0645; E-mail: jungmogg{at}hanyang.ac.kr
Objectives: The aim of this study was to assess the prevalence rate of primary fluoroquinolone resistance in Helicobacter pylori isolates from Korean patients over the past 16 years.
Methods: One hundred and thirty-five strains of H. pylori (34 strains in 1987, 36 in 1994 and 65 in 2003) were isolated from antral gastric mucosal biopsy specimens. The determination of MICs for the H. pylori isolates of ciprofloxacin, levofloxacin and moxifloxacin was examined by using the serial 2-fold agar dilution method. DNA sequences of the gyrA gene in fluoroquinolone-resistant strains were determined.
Results: The distribution of fluoroquinolone MICs (ciprofloxacin, levofloxacin and moxifloxacin) shifted to higher concentrations during 1987–2003. All of the levofloxacin- or moxifloxacin-resistant strains were resistant to ciprofloxacin. Sequence analysis in fluoroquinolone-resistant strains showed point mutation of the gyrA gene at A272G and G271A, indicating mutations of the codon Asp-91 in the fluoroquinolone-resistance-determining region of the DNA gyrase.
Conclusions: These results suggest that resistance to fluoroquinolones has been increasing in the Korean population and the resistance is most likely mediated through point mutation in gyrA.
Keywords: gyrA , mutation , QRDR , resistance
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N. Wueppenhorst, H.-P. Stueger, M. Kist, and E. Glocker Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in Germany J. Antimicrob. Chemother., April 1, 2009; 63(4): 648 - 653. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Z Jodlowski, S. Lam, and C. R Ashby Jr Emerging Therapies for the Treatment of Helicobacter pylori Infections Ann. Pharmacother., November 1, 2008; 42(11): 1621 - 1639. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Glocker, H.-P. Stueger, and M. Kist Quinolone Resistance in Helicobacter pylori Isolates in Germany Antimicrob. Agents Chemother., January 1, 2007; 51(1): 346 - 349. [Abstract] [Full Text] [PDF]
|
|